APS THIÉNABA : DES ’’ÉTUDES SONT EN COURS’’ POUR L’ÉLECTRIFICATION DU VILLAGE DE THIOTY (DG SENELEC) AIP Communiqué du Ministère de la Santé et de l’Hygiène Publique « Point de la situation de la COVID-19 au 23/10/2020 » AIP Côte d’Ivoire-AIP/Présidentielle 2020 : L’UE appelle les acteurs politiques ivoiriens à accélérer le dialogue MAP Guinée/présidentielle : 5 morts dans des violences post-électorales AGP Gabon: Reprise progressive des activités de la Société des bois de Lastourville ANP Niger : Les nouveaux membres du Comité Scientifique du CNRA se présentent au Premier Ministre ANP DIFFA : Cérémonie de présentation de semences améliorées produites par l’ONG WHH AGP Gabon : Evolution de la crise sanitaire, Task force et actualité international au menu du point de presse du Porte-parole de la Présidence APS DEUX PIROGUES DE MIGRANTS CLANDESTINS INTERCEPTÉES CE VENDREDI, AIP Côte d’Ivoire-AIP/ Le CEECI et plusieurs organisations estudiantines rendent hommage à Alassane Ouattara à l’UAO de Bouaké

FDA and GSA harmonisation of processes will reduce cost -Pharmaceutical Manufacturers


  14 Octobre      9        Santé (7775),

   

Accra, Oct. 14, GNA-The Pharmaceutical Manufacturers Association of Ghana (PMAG) has lauded the harmonisation of the processes of the Food and Drugs Authority and the Ghana Standards Authority.
It said the removal of the bottlenecks that increased cost and time of doing business, especially due to duplication of processes in the registration and certification of products was a welcome news.
Upon establishment of the Food and Drugs Authority (FDA) the continuous stringent requirements to certify FDA regulated products, Food, Drugs, Cosmetics, Household Chemicals, Herbal Medicinal products and Medical devices by the Ghana Standards Authority (GSA) led to duplication of some of the processes involved in FDA’s regulatory approval of products .
“This led to delays in acquiring regulatory and certifications for products and an increased regulatory cost which made cost and ease of doing business in Ghana not as competitive as desired,” the statement signed by Lucia Addae, Executive Secretary said.
“We applaud the Government, Ministries of Trade and Health, The CEOs of FDA, Mrs
Delese Mimi Darko and GSA, Prof Alex Dodoo for removing these bottlenecks effective 1st October 2020,” it added.
The statement said as the two regulatory bodies mandated to protect health, safety, setting standards and facilitating trade “ we as Local Pharmaceutical Manufacturers with the goal of producing to meet the needs of the local and African market are appreciative of the benefit this will bring to our members.”
The GSA certification mark, FDA number and Made in Ghana logo will go a long way to enhance standardisation and trade within the continent for our members.
The Association encouraged government to partner industry to remove such regulatory and policy bottlenecks in trade without compromising on quality and standards .
The Association expressed the hope that the two institutions with their high global and continental pedigree globally will continue to support manufacturers to project the quality made in Ghana Pharmaceutical products within and outside the country.
“We look forward to further engagements and collaboration on the implementation so that we can promote and protect the pharmaceutical industry,” the statement added.

Dans la même catégorie